معرفی
Tania Szal is a researcher at Deutsches Elektronen-Synchrotron (DESY), actively contributing to the fields of biochemistry and structural biology, with a focus on antimicrobial resistance and drug discovery. Her research investigates molecular mechanisms of bacterial efflux pumps and the biophysical properties of potential inhibitor compounds.
Her primary research interests include:
- Biochemistry
- Structural Biology
- Antimicrobial Resistance
- Drug Discovery
- Biophysics
- Molecular Biology
The available publication highlights work on 4(3-aminocyclobutyl)pyrimidin-2-amines as potential efflux pump binders. However, biophysical studies revealed these compounds form colloidal aggregates and lack specific binding, indicating they are not suitable for further drug development. This underscores the importance of screening for aggregators in early-stage drug discovery. The research combines computational (virtual screening) and experimental validation methods, reflecting an interdisciplinary approach in pharmaceutical sciences.
No scientific awards or honors are currently listed in the available records.
Tania Szal has not published a sufficient number of recent articles to establish a broad advising or grant portfolio based on the current data. There is no mention of students or supervised research projects.
Her work appears to be conducted within a structural biology or biochemical research environment at DESY, potentially involving collaboration with teams specializing in antimicrobial research and biophysical screening, although specific lab or team affiliations are not detailed in the provided sources.
